Pricing and reimbursement
AIFA intervenes in the governance of pharmaceutical expenditure by negotiating the price of medicinal products and managing the National Pharmaceutical Formulary (PFN).
In addition, AIFA monitors the appropriateness of use of medicines through the development, management and analysis of registers and consumption data.
It periodically reviews the Notes, which are regulatory tools that define the eligibility for reimbursement of some medicinal products and are updated on the basis of new scientific evidence and the needs of daily medical practice on the national territory.
Every month, the Agency also publishes the updated transparency lists, which are the lists of medicinal products whose patent coverage has expired, with the relative reference prices.
23/11/2020
23/11/2020
18/11/2020
16/11/2020
11/11/2020
10/11/2020
06/11/2020
02/11/2020
02/11/2020
29/10/2020
15/10/2020
14/10/2020
14/10/2020
29/09/2020
28/09/2020
16/09/2020
15/09/2020
27/08/2020
14/08/2020
05/08/2020
31/07/2020
29/07/2020
17/07/2020
15/07/2020
02/07/2020
19/06/2020
15/06/2020
10/06/2020
03/06/2020
25/05/2020
15/05/2020